SecBot SecBot
6-K ·Filed Jul 16, 2026

BWAY

Brainsway Ltd.
NEUTRAL
Impact 3/10
Horizonmonths Processed4mo ago SEC0001171843-26-004709
Notable filing: 6-K
Actionable Insight • Neutral

The $500K investment is too small to move the stock. Monitor for future quarterly updates on whether these minority stakes generate meaningful revenue or patient referrals for Deep TMS systems. The cross-filing 20-F showing strong fundamentals is the more relevant driver for the stock.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$14.84
T+0 close · Jul 16, 2026 · via day close
Latest settled
−20.69%
T+60 · $11.77
Vs SPY
−24.40%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 16 $14.84entry
  2. T+1 · 4mo ago +6.00%α +6.99% · $15.73
  3. T+5 · 4mo ago +11.25%α +12.92% · $16.51
  4. T+20 · 3mo ago +10.98%α +7.37% · $16.47
  5. T+60 · 6w ago −20.69%α −24.40% · $11.77
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

BrainsWay invested $500,000 for a minority stake in Sound Minds Behavioral, a Mid-Atlantic outpatient behavioral health platform, as part of its strategy to partner with growth-oriented mental health providers. The investment is small relative to BrainsWay's $596M market cap and follows a strong 20-F annual report showing 27% revenue growth to $52.2M and net income of $7.6M, but the deal itself is immaterial from a financial perspective.

Key Facts

  • BrainsWay invested $500,000 for a minority position in Sound Minds Behavioral
  • Investment structured as a preferred, annually compounding security
  • Sound Minds operates multiple locations across Connecticut, Pennsylvania, New Jersey and New York
  • This follows prior minority stake investments by BrainsWay in similar entities
  • The 20-F annual report (filed 87 days prior) showed 27% revenue growth to $52.2M and net income of $7.6M

Financial Impact

$500,000 investment represents approximately 0.08% of BrainsWay's $596M market cap, financially immaterial

cash

Risk Factors

  • Minority stakes in private clinic operators may not produce profitable returns as noted in forward-looking statement risk factors
  • Capital deployed in small strategic investments could accumulate and distract from core TMS technology focus

Market Snapshot

Exchange
OTC
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001171843-26-004709
Document: f6k_071626.htm0001171843-26-004709
Document: 0001171843-26-004709-index-headers.html0001171843-26-004709
Document: 0001171843-26-004709-index.html0001171843-26-004709
Document: 0001171843-26-004709.txt0001171843-26-004709

US Market Status

Market Closed · Opens Wed (10h 45m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 16, 2026